Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Palmer, Robert J.
and
Stoodley, Paul
2007.
Biofilms 2007: Broadened Horizons and New Emphases.
Journal of Bacteriology,
Vol. 189,
Issue. 22,
p.
7948.
Hung, E W
Darouiche, R O
and
Trautner, B W
2007.
Proteus bacteriuria is associated with significant morbidity in spinal cord injury.
Spinal Cord,
Vol. 45,
Issue. 9,
p.
616.
Valenti, August J.
2007.
Antimicrobial Resistance: Problem Pathogens and Clinical Countermeasures.
p.
397.
Lichtenberger, Paola
and
Hooton, Thomas M.
2008.
Complicated urinary tract infections.
Current Infectious Disease Reports,
Vol. 10,
Issue. 6,
p.
499.
Kanouff, Alan J.
DeHaven, Kurt D.
and
Kaplan, Peter D.
2008.
Prevention of Nosocomial Infections in the Intensive Care Unit.
Critical Care Nursing Quarterly,
Vol. 31,
Issue. 4,
p.
302.
Borchert, Dietmar H.
Sheridan, Elizabeth
Papatsoris, Athanasios
Zaman, Faruquz
Barua, Jayanta
Junaid, Islam
Pati, Jhumur
Buchholz, Noor
and
Chinegwundoh, Francis
2008.
THE CASE FOR PROBIOTICS IN UROLOGY.
BJU International,
Vol. 101,
Issue. 4,
p.
413.
Dobrindt, Ulrich
and
Hacker, Jörg
2008.
Targeting virulence traits: potential strategies to combat extraintestinal pathogenic E. coli infections.
Current Opinion in Microbiology,
Vol. 11,
Issue. 5,
p.
409.
Trautner, Barbara W.
Cevallos, Manuel E.
Li, Huaiguang
Riosa, Sarah
Hull, Richard A.
Hull, Sheila I.
Tweardy, David J.
and
Darouiche, Rabih O.
2008.
Increased Expression of Type‐1 Fimbriae by NonpathogenicEscherichia coli83972 Results in an Increased Capacity for Catheter Adherence and Bacterial Interference.
The Journal of Infectious Diseases,
Vol. 198,
Issue. 6,
p.
899.
Minocha, Anil
2009.
Probiotics for Preventive Health.
Nutrition in Clinical Practice,
Vol. 24,
Issue. 2,
p.
227.
Moussa, Sabri
Campeau, Lysanne
and
Corcos, Jacques
2009.
Indwelling catheters and neurogenic bladder: Are they really that bad?.
Current Bladder Dysfunction Reports,
Vol. 4,
Issue. 3,
p.
132.
Prasad, A
Cevallos, M E
Riosa, S
Darouiche, R O
and
Trautner, B W
2009.
A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization.
Spinal Cord,
Vol. 47,
Issue. 7,
p.
565.
Qin, Guoting
Santos, Catherine
Zhang, Wen
Li, Yan
Kumar, Amit
Erasquin, Uriel J.
Liu, Kai
Muradov, Pavel
Trautner, Barbara Wells
and
Cai, Chengzhi
2010.
Biofunctionalization on Alkylated Silicon Substrate Surfaces via “Click” Chemistry.
Journal of the American Chemical Society,
Vol. 132,
Issue. 46,
p.
16432.
Darouiche, Rabin O.
Riosa, Sarah
and
Hull, Richard A.
2010.
Comparison ofEscherichia coliStrains as Agents for Bacterial Interference.
Infection Control & Hospital Epidemiology,
Vol. 31,
Issue. 6,
p.
659.
Coudeyras, Sophie
and
Forestier, Christiane
2010.
Microbiote et probiotiques : impact en santé humaine.
Canadian Journal of Microbiology,
Vol. 56,
Issue. 8,
p.
611.
Lopez, Analette I.
Kumar, Amit
Planas, Megan R.
Li, Yan
Nguyen, Thuy V.
and
Cai, Chengzhi
2011.
Biofunctionalization of silicone polymers using poly(amidoamine) dendrimers and a mannose derivative for prolonged interference against pathogen colonization.
Biomaterials,
Vol. 32,
Issue. 19,
p.
4336.
Darouiche, Rabih O.
Green, Bruce G.
Donovan, William H.
Chen, David
Schwartz, Michael
Merritt, John
Mendez, Michelle
and
Hull, Richard A.
2011.
Multicenter Randomized Controlled Trial of Bacterial Interference for Prevention of Urinary Tract Infection in Patients With Neurogenic Bladder.
Urology,
Vol. 78,
Issue. 2,
p.
341.
Fernebro, Jenny
2011.
Fighting bacterial infections—Future treatment options.
Drug Resistance Updates,
Vol. 14,
Issue. 2,
p.
125.
Darouiche, Rabih O.
and
Hull, Richard A.
2011.
Reply.
Urology,
Vol. 78,
Issue. 2,
p.
347.
Darouiche, R. O.
and
Hull, R. A.
2012.
Bacterial Interference for Prevention of Urinary Tract Infection.
Clinical Infectious Diseases,
Vol. 55,
Issue. 10,
p.
1400.
Trautner, Barbara W.
Lopez, Analette I.
Kumar, Amit
Siddiq, Danish M.
Liao, Kershena S.
Li, Yan
Tweardy, David J.
and
Cai, Chengzhi
2012.
Nanoscale surface modification favors benign biofilm formation and impedes adherence by pathogens.
Nanomedicine: Nanotechnology, Biology and Medicine,
Vol. 8,
Issue. 3,
p.
261.